Abstract
This survey study aimed to assess readiness, amongst cardiologists and cardiology trainees, in using a polypill strategy in the management of heart failure. A national-level, 21-item survey study was conducted between 1 January 2023 and 30 June 2023. A total of 120 participants responded, with clinical practice differing greatly. Potential challenges in polypill prescription were mainly surrounding clinical safety and cost. Dosing strategies were also an important aspect, many believing that polypills should exist with various dosing combinations. In addition, evidence focused on safety and tolerability were felt important, pre-marketing. This survey demonstrates how implementation of a polypill strategy may remain challenging, especially in an Asia-Pacific community.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
